These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 9935073

  • 1. Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry.
    Nikula TK, McDevitt MR, Finn RD, Wu C, Kozak RW, Garmestani K, Brechbiel MW, Curcio MJ, Pippin CG, Tiffany-Jones L, Geerlings MW, Apostolidis C, Molinet R, Geerlings MW, Gansow OA, Scheinberg DA.
    J Nucl Med; 1999 Jan; 40(1):166-76. PubMed ID: 9935073
    [Abstract] [Full Text] [Related]

  • 2. Preparation of alpha-emitting 213Bi-labeled antibody constructs for clinical use.
    McDevitt MR, Finn RD, Ma D, Larson SM, Scheinberg DA.
    J Nucl Med; 1999 Oct; 40(10):1722-7. PubMed ID: 10520715
    [Abstract] [Full Text] [Related]

  • 3. Radiolabeled anti-CD33 monoclonal antibody M195 for myeloid leukemias.
    Jurcic JG, Caron PC, Nikula TK, Papadopoulos EB, Finn RD, Gansow OA, Miller WH, Geerlings MW, Warrell RP, Larson SM.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5908s-5910s. PubMed ID: 7493368
    [Abstract] [Full Text] [Related]

  • 4. An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.
    McDevitt MR, Barendswaard E, Ma D, Lai L, Curcio MJ, Sgouros G, Ballangrud AM, Yang WH, Finn RD, Pellegrini V, Geerlings MW, Lee M, Brechbiel MW, Bander NH, Cordon-Cardo C, Scheinberg DA.
    Cancer Res; 2000 Nov 01; 60(21):6095-100. PubMed ID: 11085533
    [Abstract] [Full Text] [Related]

  • 5. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W.
    Cancer Res; 1999 Jun 01; 59(11):2635-43. PubMed ID: 10363986
    [Abstract] [Full Text] [Related]

  • 6. Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells.
    Chen P, Wang J, Hope K, Jin L, Dick J, Cameron R, Brandwein J, Minden M, Reilly RM.
    J Nucl Med; 2006 May 01; 47(5):827-36. PubMed ID: 16644753
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia.
    Sgouros G, Ballangrud AM, Jurcic JG, McDevitt MR, Humm JL, Erdi YE, Mehta BM, Finn RD, Larson SM, Scheinberg DA.
    J Nucl Med; 1999 Nov 01; 40(11):1935-46. PubMed ID: 10565792
    [Abstract] [Full Text] [Related]

  • 8. In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates.
    Milenic DE, Roselli M, Mirzadeh S, Pippin CG, Gansow OA, Colcher D, Brechbiel MW, Schlom J.
    Cancer Biother Radiopharm; 2001 Apr 01; 16(2):133-46. PubMed ID: 11385960
    [Abstract] [Full Text] [Related]

  • 9. Antileukemic activity of recombinant humanized M195-gelonin immunotoxin in nude mice.
    Xu Y, Xu Q, Rosenblum MG, Scheinberg DA.
    Leukemia; 1996 Feb 01; 10(2):321-6. PubMed ID: 8637241
    [Abstract] [Full Text] [Related]

  • 10. Radioimmunotherapy with alpha-particle emitting 213Bi-C-functionalized trans-cyclohexyl-diethylenetriaminepentaacetic acid-humanized 3S193 is enhanced by combination with paclitaxel chemotherapy.
    Kelly MP, Lee FT, Tahtis K, Smyth FE, Brechbiel MW, Scott AM.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 2):5604s-5612s. PubMed ID: 17875796
    [Abstract] [Full Text] [Related]

  • 11. A phase I trial of humanized monoclonal antibody HuM195 (anti-CD33) with low-dose interleukin 2 in acute myelogenous leukemia.
    Kossman SE, Scheinberg DA, Jurcic JG, Jimenez J, Caron PC.
    Clin Cancer Res; 1999 Oct 15; 5(10):2748-55. PubMed ID: 10537338
    [Abstract] [Full Text] [Related]

  • 12. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
    Brouwers AH, van Eerd JE, Frielink C, Oosterwijk E, Oyen WJ, Corstens FH, Boerman OC.
    J Nucl Med; 2004 Feb 15; 45(2):327-37. PubMed ID: 14960657
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates.
    Miederer M, McDevitt MR, Sgouros G, Kramer K, Cheung NK, Scheinberg DA.
    J Nucl Med; 2004 Jan 15; 45(1):129-37. PubMed ID: 14734685
    [Abstract] [Full Text] [Related]

  • 14. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
    Hartmann F, Horak EM, Garmestani K, Wu C, Brechbiel MW, Kozak RW, Tso J, Kosteiny SA, Gansow OA, Nelson DL.
    Cancer Res; 1994 Aug 15; 54(16):4362-70. PubMed ID: 8044783
    [Abstract] [Full Text] [Related]

  • 15. Treatment of relapsed or refractory acute myeloid leukemia with humanized anti-CD33 monoclonal antibody HuM195.
    Feldman E, Kalaycio M, Weiner G, Frankel S, Schulman P, Schwartzberg L, Jurcic J, Velez-Garcia E, Seiter K, Scheinberg D, Levitt D, Wedel N.
    Leukemia; 2003 Feb 15; 17(2):314-8. PubMed ID: 12592328
    [Abstract] [Full Text] [Related]

  • 16. 213Bi radioimmunotherapy with an anti-mCD138 monoclonal antibody in a murine model of multiple myeloma.
    Chérel M, Gouard S, Gaschet J, Saï-Maurel C, Bruchertseifer F, Morgenstern A, Bourgeois M, Gestin JF, Bodéré FK, Barbet J, Moreau P, Davodeau F.
    J Nucl Med; 2013 Sep 15; 54(9):1597-604. PubMed ID: 24003167
    [Abstract] [Full Text] [Related]

  • 17. Efforts to control the errant products of a targeted in vivo generator.
    Jaggi JS, Kappel BJ, McDevitt MR, Sgouros G, Flombaum CD, Cabassa C, Scheinberg DA.
    Cancer Res; 2005 Jun 01; 65(11):4888-95. PubMed ID: 15930310
    [Abstract] [Full Text] [Related]

  • 18. Radioimmunotherapy of micrometastases in lung with vascular targeted 213Bi.
    Kennel SJ, Boll R, Stabin M, Schuller HM, Mirzadeh S.
    Br J Cancer; 1999 Apr 01; 80(1-2):175-84. PubMed ID: 10389994
    [Abstract] [Full Text] [Related]

  • 19. Fractionated locoregional low-dose radioimmunotherapy improves survival in a mouse model of diffuse-type gastric cancer using a 213Bi-conjugated monoclonal antibody.
    Bloechl S, Beck R, Seidl C, Morgenstern A, Schwaiger M, Senekowitsch-Schmidtke R.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 2):7070s-7074s. PubMed ID: 16203804
    [Abstract] [Full Text] [Related]

  • 20. Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia.
    Caron PC, Dumont L, Scheinberg DA.
    Clin Cancer Res; 1998 Jun 01; 4(6):1421-8. PubMed ID: 9626458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.